Advanced search
Publication Cover
Pediatric Rehabilitation Volume 6, 2003 - Issue 2
Journal homepage
67
Views
12
CrossRef citations to date
0
Altmetric
Research Article

Evidence-based approach of the use of Botulinum toxin type A (BTX) in cerebral palsy

Virginia Wong Division of Neurodevelopmental Paediatrics, Department of Pediatrics & Adolescent Medicine The University of Hong Kong Hong Kong PR China [email protected]
Pages 85-96 | Published online: 10 Jul 2009

  • BRIN, M. F.: Botulinum toxin: chemistry, pharmacology, toxicity, and immunology. Muscle Nerve Suppl, 6: S146-S168, 1997.
  • JANKOVIC, J. and BRIN, M. P.: Botulinum toxin: historical perspective and potential new indications. Muscle Nerve Suppl, 6: S129-S145, 1997.
  • SIMPSON, D. M.: Clinical trials of botulinum toxin in the treatment of spasticity. Muscle Nerve Suppl, 6: Sl69-Sl75, 1997.
  • COSGROVE, A. P. and GRAHAM, H. K.: Botulinum toxin A prevents the development of contractures in the hereditary spastic mouse. Developments in Medicine and Child Neurology, 36: 379385, 1994.
  • FORRSBERG, H. and TEDROFF. K. B.: Botulinum toxin treatment in cerebral palsy: intervention with poor evaluation? Developments in Medicine and Child Neurology, 39: 635-640,1997.
  • COCHRANE, W.: The combination of estimates from different experiments. Biometrics, 10: 101-129, 1954.
  • CLARKE, M. H.: Cochrane Reviewers' Handbook 4.1. [www. cochrane.de/cochrane/hbook.htm] (Oxford, UK: The Cochrane Collaboration), 2000.
  • SACKETT, D., STRAUS, S. E., RICHARDSON, W. S. et al.: Evidencebased Medicine, 2nd edn (Churchill Livingstone), 2000.
  • RUSSMAN, B. S., TILTON, A. and GORMLEY JR., M. E.: Cerebral palsy: a rational approach to a treatment protocol, and the role of botulinum toxin in treatment. Muscle Nerve Suppl, 6: S181-S193, 1997.
  • CARR, L. J., COSGROVE, A. P., GRINGRAS, P. et al.: Position paper on the use of botulinum toxin in cerebral palsy. UK Botulinum toxin and Cerebral Palsy Working Party. Archives of Diseases in Children, 79: 271-273, 1998.
  • GRAHAM, H. K., AOKI, K. R., AUTTI-RAMO, I. et al.: Recommendations for the use of botulinum toxin type A in the management of cerebral palsy. Gait and Posture, 11: 67-79, 2000.
  • GRAHAM, H.: Botulinum toxin A in cerebral palsy: functional outcomes. Journal of Paediatrics, 137: 300-303, 2000.
  • ADE-HALL, R. A. and MOORE, A. P.: Botulinum toxin type A in the treatment of lower limb spasticity in cerebral palsy. Cochrane Database System Review, 2: CD001408, 2000.
  • PETERSEN, M. C. and PALMER, F. B.: Advances in prevention and treatment of cerebral palsy. Mental Retardation Developments and Disability Research Review, T. 30-37, 2001.
  • KIRSCHNER, J., BERWECK, S., MALL, V. et al.: Botulinum toxin treatment in cerebral palsy: evidence for a new treatment option. Journal of Neurology, 24» (suppl 1): 28-30, 2001.
  • EDGAR, T. S.: Clinical utility of botulinum toxin in the treatment of cerebral palsy: comprehensive review. Journal of Child Neurology, 16: 37-46, 2001.
  • HOULTRAM, J., NOBLE, I., BOYD, R. N. et al.: Botulinum toxin type A in the management of equinus in children with cerebral palsy: an evidence-based economic evaluation. European Journal of Neurology, 8 (suppl 5): 194-202, 2001.
  • BOYD, R. N. and HAYS, R. M.: Current evidence for the use of botulinum toxin type A in the management of children with cerebral palsy: a systematic review. European Journal of Neurology, 8 (suppl 5): 1-20, 2001.
  • BOYD, R. N. and HAYS, R. M.: Outcome measurement of effectiveness of botulinum toxin type A in children with cerebral palsy: an ICIDH-2 approach. European Journal of Neurology, 8 (suppl 5): 167-177, 2001.
  • WASIAK, J., WALLEN, M., VILLANUEVA, E. et al.: Botulinum toxin type A in the treatment of upper limb plasticity in children with cerebral palsy (protocol in the Cochrane Database of Systematic Reviews, [www.cochranelibrary.com/enter/]). The Cochrane Library, 1:, 2001.
  • KOMAN, L. A., MOONEY, J. F. 3rd, SMITH, B. et al.: Management of cerebral palsy with botulinum-A toxin: preliminary investigation. Journal of Pediatric Orthopedics, 13: 489-495, 1993.
  • CORRY, I. S., COSGROVE, A. P., DUFFY, C. M. et al.: Botulinum toxin A compared with stretching casts in the treatment of spastic equinus: a randomized prospective trial. Journal of Paediatric Orthopaedics, 18: 304-311, 1998.
  • WISSEL, J., HEIMEN, F., SCHENKEL, A. et al.: Botulinum toxin A in thé management of spastic gait disorders in children and young adults with cerebral palsy: a randomized, double-blind study of 'high-dose' versus 'low-dose' treatment. Neuropediatrics, 30: 120124, 1999.
  • SUTHERLAND, D. H., KAUFMAN, K. R., WYATT, M. P. et al.: Double-blind study of botulinum A toxin injections into the gastrocnemius muscle in patients with cerebral palsy. Gait Posture, 10: 1-9, 1999.
  • UBHI, T., BHAKTA, B. B., IVES, H. L. et al.: Randomized doubleblind placebo-controlled trial of the effect of botulinum toxin on walking in cerebral palsy. Archives of Diseases in Children, 83: 481-487, 2000.
  • KOMAN, L. A., MOONEY, J. F. 3rd, SMITH, B. P. et al.: Botulinum toxin type A neuromuscular blockade in the treatment of lower extremity spasticity in cerebral palsy: a randomized, double-blind, placebo-controlled trial. BOTOX Study Group. Journal of Pediatrie Orthopedics, 20: 108-115, 2000.
  • BOYD, R. N., DOBSON, F., PARROTT, J. et al.: The effect of botulinum toxin type A and a variable hip abduction orthosis on gross motor function: a randomized controlled trial. European Journal of Neurology, 8 (suppl 5): 109-119, 2001.
  • LOVE, S. C., VALENTINE, J. P., BLAIR, E. M. et al.: The effect of botulinum toxin type A on the functional ability of the child with spastic hemiplegia a randomized controlled trial. European Journal of Neurology, 8 (suppl 5): 50-58, 2001.
  • REDDIHOUGH, D. S., KING, J. A., FOSANG, A. et al.: Functional outcome of botulinum toxin A injections to the lower limbs in cerebral palsy. Developments in Medicine and Child Neurology, 44: 820-827, 2002.
  • POLAK, F., MORTON, R., WARD, C. et al.: Double-blind comparison study of two doses of botulinum toxin A injected into calf muscles in children with hemiplegie cerebral palsy. Developments in Medicine and Child Neurology, 44: 551-555, 2002.
  • BAKER, R., JASINSKI, M., MACIAG-TYMECKA, I. et al.: Botulinum toxin treatment of spasticity in diplegic cerebral palsy: a randomized, double-blind, placebo-controlled, dose-ranging study. Developments in Medicine and Child Neurology, 44: 666-675,2002.
  • CALDERON-GONZALEZ, R., CALDERON-SEPULVEDA, R., RINCONREYES, M. et al.: Botulinum toxin A in management of cerebral palsy. Pediatrie Neurology, 10: 284-288, 1994.
  • DENISLIC, M. and MEH, D.: Botulinum toxin in the treatment of cerebral palsy. Neuropediatrics, 26: 249-252, 1995.
  • MEINEN, F., WISSEL, J., PHILIPSEN, A. et al.: International neuropediatrics: treatment of dystonic and spastic muscular hyperactivity with botulinum toxin A. Neuropediatrics, 28: 307313, 1997.
  • ARENS, L. J., LEARY, P. M. and GOLDSCHMIDT, R. B.: Experience with botulinum toxin in the treatment of cerebral palsy. South African Medical Joumal, 87: 1001-1003, 1997.
  • MALL, V., HEINEN, F., LINDER, M. et al.: Treatment of cerebral palsy with botulinum toxin A: functional benefit and reduction of disability. Three case reports. Pediatrie Rehabilitation, 1:235-237, 1997.
  • ZELNIK, N., GILADI, N., GOIKHMAN, I. et al.: The role of botulinum toxin in the treatment of lower limb spasticity in children with cerebral palsy--a pilot study. Israeli Journal of Medical Science, 33: 129-133, 1997.
  • WONG, V.: Use of botulinum toxin injection in 17 children with spastic cerebral palsy. Pediatric Neurology, 18: 124-131, 1998.
  • EAMES, N. W., BAKER, R., HILL, N. et al.: The effect of botulinum toxin A on gastrocnemius length: magnitude and duration of response. Developments in Medicine and Child Neurology, 41: 226-232, 1999.
  • ROCCELLA, M.: The type A botulinum toxin in the treatment of spasticity in evolutive age. Minerva Pediatrics, 51: 367-373, 1999.
  • CORRY, I. S., COSGROVE, A. P., DUFFY, C. M. et al.: Botulinum toxin A in hamstring spasticity. Gait Posture, 10: 206-210, 1999.
  • FLETT, P. J., STERN, L. M., WADDY, H. et al.: Botulinum toxin A versus fixed cast stretching for dynamic calf tightness in cerebral palsy. Journal of Paediatric Child Health, 35: 71-77, 1999.
  • BOYD, R. N., PLIATSIOS, V., STARR, R. et al.: Biomechanical transformation of the gastroc-soleus muscle with botulinum toxin A in children with cerebral palsy. Developments in Medicine and Child Neurology, 42: 32-41, 2000.
  • FRIEDMAN, A., DIAMOND, M., JOHNSTON, M. V. et al.: Effects of botulinum toxin A on upper limb spasticity in children with cerebral palsy. American Journal of Physical Medicine Rehabilitation, 79: 53-59; quiz 75-76, 2000.
  • SUPUTTITADA, A.: Managing spasticity in pédiatrie cerebral palsy using a very low dose of botulinum toxin type A: preliminary report. American Journal of Physical Medicine Rehabilitation, 79: 320-326, 2000.
  • GARCIA RUIZ, P. J., PASCUAL PASCUAL, I. and SANCHEZ BERNARDOS, V.: Progressive response to botulinum A toxin in cerebral palsy. European Journal of Neurology, 7: 191-193, 2000.
  • UBHI, T.: Treatment of paediatric cerebral palsy with Dysport. Hospital Medicine, 61: 718-721, 2000.
  • JACOBS, J. M.: Management options for the child with spastic cerebral palsy. Orthopedic Nursing, 20: 53-59; quiz 59-61, 2001.
  • BJORNSON, K. F. and MCLAUGHLIN, J. F.: The measurement of health-related quality of life (HRQL) in children with cerebral palsy. European Journal of Neurology, 8 (suppl 5): 183-193, 2001.
  • CHAMBERS, H. G.: Treatment of functional limitations at the knee in ambulatory children with cerebral palsy. European Journal of Neurology, 8 (suppl 5): 59-74, 2001.
  • DAMIANO, D. L., QUINLIVAN, J., OWEN, B. F. et al.: Spasticity versus strength in cerebral palsy: relationships among involuntary resistance, voluntary torque, and motor function. European Journal of Neurology, 8 (suppl 5): 40-49, 2001.
  • KOMAN, L. A., BRASHEAR, A., ROSENFELD, S. et al.: Botulinum toxin type a neuromuscular blockade in the treatment of equinus foot deformity in cerebral palsy: a multicenter, open-label clinical trial. Pediatrics, 108: 1062-1071, 2001.
  • BAKHEIT, A. M., SEVERA, S., COSGROVE, A. et al.: Safety profile and efficacy of botulinum toxin A (Dysport) in children with muscle spasticity. Developments in Medicine and Child Neurology, 43: 234-238, 2001.
  • LINDER, M., SCHINDLER, G., MICHAELIS, U. et al.: Medium-term functional benefits in children with cerebral palsy treated withbotulinum toxin type A: 1-year follow-up using gross motor function measure. European Journal of Neurology, 8 (suppl 5): 120-126, 2001.
  • GORMLEY, M. E., GAEBLER-SPIRA, D. and DELGADO, M. R.: Use of botulinum toxin type A in pediatrie patients with cerebral palsy: a three-center retrospective chart review. Journal of Child Neurology, 16: 113-118, 2001.
  • DETREMBLEUR, C., LEJEUNE, T. M., RENDERS, A. et al.: Botulinum toxin and short-term electrical stimulation in the treatment of equinus in cerebral palsy. Movement Disorders, 17: 162169, 2002.
  • DURSUN, N., DURSUN, E. and ALICAN, D.: The role of botulinum toxin A in the management of lower limb spasticity in patients with cerebral palsy. International Journal of Clinical Practice, 56: 564-567, 2002.
  • PARK, E. S., PARK, C. I., KIM, D. Y. et al.: The effect of spasticity on cortical somatosensory-evoked potentials: changes of cortical somatosensory-evoked potentials after botulinum toxin type A injection. Archives in Physical Medicine Rehabilitation, 83: 15921596, 2002.
  • BAKER, R., JASINSKI, M., MACIAG-TYMECKA, I. et al.: Botulinum toxin treatment of spasticity in diplegic cerebral palsy: a randomized, double-blind, placebo-controlled, dose-ranging study. Developments in Medicine and Child Neurology, 44: 666-675, 2002.
  • BANG, M. S., CHUNG, S. G., KIM, S. B. et al.: Change of dynamic gastrocnemius and soleus muscle length after block of spastic calf muscle in cerebral palsy. American Journal of Physical Medicine Rehabilitation, 81: 760-764, 2002.
  • HEINEN, F., LINDER, M., MALL, V. et al.: Adductor spasticity in children with cerebral palsy and treatment with botulinum toxin type A--the parents' view of functional outcome. European Journal of Neurology, 6 (suppl 4): S47-S50, 1999.
  • MALL, V., MEINEN, F., KIRSCHNER, J. et al.: Botulinum toxin A in children with adductor spasm: evaluation of therapy using gross motor function measure. Journal of Child Neurology, 15: 214-217, 2000.
  • WILLENBORG, M. J., SHILT, J. S., SMITH, B. P. et al.: Technique for iliopsoas ultrasound-guided active electromyography-directed botulinum A toxin injection in cerebral palsy. Journal of Pediatrie Orthopaedics, 22: 165-168, 2002.
  • KETELAAR, M., VERMEER, A. and HELDERS, P.: Functional motor abilities of children with cerebral palsy: a systematic literature review of assessment measures. Clinical Rehabilitation, 12: 369380, 1998.
  • BARWOOD, S., BAILLIEU, C., BOYD, R. et al.: Analgesic effects of botulinum toxin A: a randomized, placebo-controlled clinical trial. Developments in Medicine and Child Neurology, 42: 116121, 2000.
  • FATTAL-VALEVSKI, A., GILADI, N., DOMANIEVITZ, D. et al.: Parameters for predicting favorable responses to botulinum toxin in children with cerebral palsy. Journal of Child Neurology, 17: 272-277, 2002.
  • CORRY, I. S., COSGROVE, A. P., WALSH, E. G. et al.: Botulinum toxin A in the hemiplegic upper limb: a double-blind trial. Developments in Medicine and Child Neurology, 39: 185-193,1997.
  • FEHLINGS, D., RANG, M., GLAZIER, J. et al.: An evaluation of botulinum A toxin injections to improve upper extremity function in children with hemiplegic cerebral palsy. Journal of Pediatrics, 137: 331-337, 2000
  • FEHLINGS, D., RANG, M., GLAZIER, J. et al.: Botulinum toxin type A injections in the spastic upper extremity of children with hemiplegia: child characteristics that predict a positive outcome. European Journal of Neurology, 8 (suppl 5): 145-149, 2001.
  • AUTTI-RAMO, I., LARSEN, A., TAIMO, A. et al.: Management of the upper limb with botulinum toxin type A in children with spastic type cerebral palsy and acquired brain injury: clinical implications. European Journal of Neurology, 8 (suppl 5): 136144, 2001.
  • AUTTI-RAMO, I., LARSEN, A., PELTONEN, J. et al.: Botulinum toxin injection as an adjunct when planning hand surgery in children with spastic hemiplegia. Newopediatrics, 31: 4-8, 2000.
  • WONG, V., No, A. and SIT, P.: Open-label study of botulinum toxin for upper limb spasticity in cerebral palsy. Journal of Child Neurology, 17: 138-142, 2002.
  • BOYD, R. N., MORRIS, M. E. and GRAHAM, H. K.: Management of upper limb dysfunction in children with cerebral palsy: a systematic review. European Journal of Neurology, 8 (suppl 5): 150166, 2001.
  • JONGERIUS, P. H., ROTTEVEEL, J. J., VANDEN HOOGEN, F. et al.: Botulinum toxin A: a new option for treatment of drooling in children with cerebral palsy. Presentation of a case series. European Journal of Pediatrics, 160: 509-512, 2001.
  • BOTHWELL, J. E., CLARKE, K., DOOLEY, J. M. et al.: Botulinum toxin A as a treatment for excessive drooling in children. Pediatrie Neurology, 27: 18-22, 2002.
  • SUSKIND, D. L. and TILTON, A.: Clinical study of Botulinum-A toxin in the treatment of sialorrhea in children with cerebral palsy. The Larynscope, 112: 73-81, 2002.
  • JONGERIUS, P. H., JOOSTEN, F., HOOGEN, F. J. A. et al.: The treatment of drooling by ultrasound-guided intraglandular injections of Botulinum toxin type A into the salivary glands. The Laryngoscope, 113: 107-111, 2003.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.